Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2485422 | Journal of Pharmaceutical Sciences | 2012 | 8 Pages |
Abstract
The objectives of this study were to determine the potential systemic and local toxicity, as well as evaluate the toxicokinetic (TK) profile of angiotensin (1-7) [A(1-7)] when administered daily via subcutaneous injection for 28Â days to Sprague-Dawley rats and Beagle dogs. A(1-7) is a member of the renin-angiotensin system and has undergone clinical evaluation for the treatment of chemotherapy-induced myelosuppression. In this present study, A(1-7) was given at 10Â mg/(kg day) for 28Â days to rats and canines. At day 27, blood was harvested to evaluate the TK parameters. On day 28, systemic toxicology was evaluated. Following A(1-7) administration for 27Â days, no plasma A(1-7) accumulation was detected in canines; however, increased A(1-7) plasma concentrations were detected in rats. Despite the accumulation observed in rats, no detectable toxicity was found following A(1-7) administration for 28Â days. The TK analysis of A(1-7) revealed a plasma half-life of 20-30Â min in both rats and canines. The time to maximum plasma concentration was found to be 15 and 26.25Â min in rats and canines, respectively. This study shows that subcutaneous administration of A(1-7) at 10Â mg/(kg day) for 28Â days did not lead to any detectable toxicities in either rats or canines. © 2011 Wiley Periodicals, Inc. and the American Pharmacists Association.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Nicholas M. Mordwinkin, Jared R. Russell, Angela S. Burke, Gere S. Dizerega, Stan. G. Louie, Kathleen E. Rodgers,